Nefrologia

Revisão sistemática | Anticoagulação regional com citrato e anticoagulação sistêmica durante terapia de substituição renal contínua pediátrica.

19 Jun, 2022 | 14:51h

Regional Citrate Anticoagulation and Systemic Anticoagulation during Pediatric Continuous Renal Replacement Therapy: A Systematic Literature Review – Journal of Clinical Medicine

---

Revisão sistemática | Recomendações de diretrizes de prática clínica de alta qualidade relacionadas ao processo de diálise inicial.

19 Jun, 2022 | 13:52h

Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: A systematic review – PLOS One

---

Diretrizes para o tratamento de hipertensão.

19 Jun, 2022 | 13:29h

2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension – Acta Cardiologica Sinica

---

Diretriz de posicionamento | Tratamento da doença renal diabética.

19 Jun, 2022 | 13:28h

The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD – Diabetology & Metabolic Syndrome

---

Inibidor de SGLT2 reduz o risco de hiperpotassemia em pacientes com insuficiência cardíaca.

19 Jun, 2022 | 13:15h

Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled – European Heart Journal

Editorial: Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure

Conteúdo relacionado: Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial – European Heart Journal

 

Comentário no Twitter

More evidence that SGLT2i ⬇️ hyperK, this time in heart failure

Empagliflozin reduces:
– K>6.0: HR 0.62 95% CI 0.48–0.81
– Investigator reported hyperK or K binders, HR 0.82 95% CI 0.71-0.95
– Effect modified by GFR – larger in CKD
– Regardless of MRAshttps://t.co/t4T7II1G8p pic.twitter.com/RP1EUKXHyV

— Brendon Neuen (@brendonneuen) June 12, 2022

Sob a licença de https://creativecommons.org/licenses/by-nc/4.0/

---

Associação entre a taxa de filtração glomerular (TFG) estimada calculada por meio de equações que desconsideram a etnia e a insuficiência renal e a mortalidade de pessoas negras vs. não negras.

14 Jun, 2022 | 14:00h

Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race – JAMA

Editorial: Race-Free Estimation of Kidney Function: Clearing the Path Toward Kidney Health Equity

Comunicado de imprensa: Kidney failure experts recommend new tool that eliminates race as a determining factor for diagnosis – University of Alabama at Birmingham

Landmark articles suggest eliminating race in the estimation of kidney function.

Expert panel recommends against use of race in assessment of kidney function – STAT

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease – American Journal of Kidney Diseases

---

M-A | Eficácia comparativa de novos medicamentos antidiabéticos sobre os desfechos cardiovasculares e renais em pacientes com doença renal diabética.

14 Jun, 2022 | 13:08h

Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease: A systematic review and network meta-analysis – Diabetes, Obesity & Metabolism

---

Estudo randomizado | Efeito da dexmedetomidina perioperatória sobre a função tardia do enxerto após transplante de rim doado após morte cardíaca.

14 Jun, 2022 | 12:51h

Effect of Perioperative Dexmedetomidine on Delayed Graft Function Following a Donation-After-Cardiac-Death Kidney Transplant: A Randomized Clinical Trial – JAMA Network Open

 

Comentário no Twitter

In this RCT, 24-hour dexmedetomidine infusion, started immediately after induction of & in addition to standard anesthesia, reduced the incidence of delayed graft function vs placebo, following a donation-after-cardiac-death kidney transplantation. https://t.co/cmX1IEZdVX

— JAMA Network Open (@JAMANetworkOpen) June 3, 2022

 

---

Diretriz | Avaliação e manejo médico do paciente com cálculo renal.

6 Jun, 2022 | 11:26h

Update – 2022 Canadian Urological Association guideline: Evaluation and medical management of the kidney stone patient – Canadian Urological Association Journal

---

Compreensão do excesso de base (base excess – BE).

2 Jun, 2022 | 13:51h

Understanding base excess (BE): merits and pitfalls – Intensive Care Medicine (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

Understanding base excess
🧪 valuable quantitative estimate of metabolic acid-base derangements, but not info on underlying mechanisms
🧪 standard BE composite marker: several components contribute; interpretation of isolated value very difficult#FOAMcc
🖇️https://t.co/T8pcVRrTgR pic.twitter.com/6TEFsFTJR1

— Intensive Care Medicine (@yourICM) May 31, 2022

 

---